BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025

Month

• January
• February
• March
• April
• May
• June
• July

Day

• 2
• 3
• 4
• 5
• 6
• 7
• 9
• 10
• 11
• 12
• 13
• 14
• 17
• 18
• 19
• 20
• 21
• 24
• 25
• 26
• 27
• 28

• Press Releases

  Codexis Announces New Employment Inducement Grants - February 14, 2025

  February 17, 2025

   · 

  1 min read
• Press Releases

  Citius Pharmaceuticals, Inc. Reports Fiscal First Quarter 2025 Financial Results and Provides Business Update

  February 17, 2025

   · 

  12 min read
• Press Releases

  Onco-Innovations’ Nanoparticle Formulation PNKP Technology Combined with Radiation Therapy, and as a Standalone Treatment, Shown in Studies to Slow Colorectal Cancer Tumour Growth

  February 17, 2025

   · 

  9 min read
• Press Releases

  Exelixis Announces Final Five-Year Follow-up Results from CheckMate -9ER Trial Evaluating CABOMETYX® (cabozantinib) in Combination with Opdivo® (nivolumab) in Patients with Advanced Kidney Cancer at ASCO GU 2025

  February 17, 2025

   · 

  17 min read
• Press Releases

  FDA Approves Samsung Bioepis’ OSPOMYV™, XBRYK™ (denosumab-dssb), a Biosimilar to Prolia and Xgeva

  February 17, 2025

   · 

  9 min read
• Press Releases

  Innovent Receives Second Fast Track Designation from the U.S. FDA for IBI363 (PD-1/IL-2α-bias Bispecific Antibody Fusion Protein) in Squamous Non-Small Cell Lung Cancer

  February 17, 2025

   · 

  7 min read
• Press Releases

  Innate Pharma Announces U.S. FDA Granted Breakthrough Therapy Designation to Lacutamab for Relapsed or Refractory Sézary Syndrome

  February 17, 2025

   · 

  9 min read
• Press Releases

  Fosun Pharma Deeply Embraces AI, Self-developed PharmAID Decision Intelligence Platform Boosts Efficient Innovation

  February 17, 2025

   · 

  7 min read
• Press Releases

  Orthofix to Participate in the Canaccord Genuity 2025 Musculoskeletal Conference

  February 17, 2025

   · 

  1 min read
• Press Releases

  PENMENVY, GSK’s 5-in-1 Meningococcal Vaccine, Approved by US FDA to Help Protect Against MenABCWY

  February 17, 2025

   · 

  13 min read